[
  {
    "ts": null,
    "headline": "Pfizer Jumps After Avoiding Proxy Fight With Activist Investor Starboard — For Now",
    "summary": "Pfizer Jumps After Avoiding Proxy Fight With Activist Investor Starboard — For Now",
    "url": "https://finnhub.io/api/news?id=2288948689e43e996c116538c3a8f95451d5bbcf4f7e480bce4ae81624158b02",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737994864,
      "headline": "Pfizer Jumps After Avoiding Proxy Fight With Activist Investor Starboard — For Now",
      "id": 132523307,
      "image": "",
      "related": "PFE",
      "source": "DowJones",
      "summary": "Pfizer Jumps After Avoiding Proxy Fight With Activist Investor Starboard — For Now",
      "url": "https://finnhub.io/api/news?id=2288948689e43e996c116538c3a8f95451d5bbcf4f7e480bce4ae81624158b02"
    }
  },
  {
    "ts": null,
    "headline": "Liquidity Up, Markets Up, Liquidity Down, Markets Down",
    "summary": "Why Kirk Spano thinks there is potential for dislocations in the economy and markets.",
    "url": "https://finnhub.io/api/news?id=a56e17992710f80a83bec8ceaa67347df4dbc4cb2aac362e63993453d59681fc",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737984600,
      "headline": "Liquidity Up, Markets Up, Liquidity Down, Markets Down",
      "id": 132480710,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/505147573/image_505147573.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Why Kirk Spano thinks there is potential for dislocations in the economy and markets.",
      "url": "https://finnhub.io/api/news?id=a56e17992710f80a83bec8ceaa67347df4dbc4cb2aac362e63993453d59681fc"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer s BRAFTOVI Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer",
    "summary": "NEW YORK - Pfizer Inc. today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI in combination with cetuximab and mFOLFOX6 in patients with metastatic colorectal...",
    "url": "https://finnhub.io/api/news?id=e9876a85d158dd556f702c26ee29b66a19769cd297aa6e25d144929a430cdae8",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737975924,
      "headline": "Pfizer s BRAFTOVI Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer",
      "id": 132479971,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "NEW YORK - Pfizer Inc. today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI in combination with cetuximab and mFOLFOX6 in patients with metastatic colorectal...",
      "url": "https://finnhub.io/api/news?id=e9876a85d158dd556f702c26ee29b66a19769cd297aa6e25d144929a430cdae8"
    }
  },
  {
    "ts": null,
    "headline": "Four Years After Covid-19 Success, mRNA Vaccines Aren’t Ready for Bird Flu",
    "summary": "Four Years After Covid-19 Success, mRNA Vaccines Aren’t Ready for Bird Flu",
    "url": "https://finnhub.io/api/news?id=8f162c8a017aef1dc9207eaf4e86b41e252e5f4c825ad4eac7433c3f024fa36f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737966780,
      "headline": "Four Years After Covid-19 Success, mRNA Vaccines Aren’t Ready for Bird Flu",
      "id": 132523328,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Four Years After Covid-19 Success, mRNA Vaccines Aren’t Ready for Bird Flu",
      "url": "https://finnhub.io/api/news?id=8f162c8a017aef1dc9207eaf4e86b41e252e5f4c825ad4eac7433c3f024fa36f"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: conclusive colorectal cancer treatment trial",
    "summary": "Pfizer announces that a Phase 3 trial has demonstrated that the combination of Braftovi , cetuximab and mFOLFOX6 significantly improved the objective response rate for the treatment of metastatic...",
    "url": "https://finnhub.io/api/news?id=cbbcbb421ddc10e50ad8d98f1ae79ca06dcce3abb0172d06d99d7893d393c17d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737960253,
      "headline": "Pfizer: conclusive colorectal cancer treatment trial",
      "id": 132478548,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Pfizer announces that a Phase 3 trial has demonstrated that the combination of Braftovi , cetuximab and mFOLFOX6 significantly improved the objective response rate for the treatment of metastatic...",
      "url": "https://finnhub.io/api/news?id=cbbcbb421ddc10e50ad8d98f1ae79ca06dcce3abb0172d06d99d7893d393c17d"
    }
  }
]